Tribunal overrules findings in case involving epilepsy drug
A decision by the Competition and Markets Authority to fine Pfizer and Flynn Pharma a total of £90m for overcharging for an epilepsy drug, has been remitted back to the CMA after a tribunal ruled against the government watchdog's decision.
Epilepsy Society welcomes new measures to ensure no babies are exposed to sodium valproate during pregnancy
New measures announced to stop babies being exposed to valproate in the womb Valproate medicines are available in the UK under brand names such as Epilim, Epival, Episenta, Convulex and Orlept No girl or woman should stop taking valproate without first consulting her doctor.
Clare Pelham joins expert group on sodium valproate
Epilepsy Society's chief executive Clare Pelham has joined the Sodium Valproate Expert Working Group which supports the Government's Commission on Human Medicines.
Health secretary Jeremy Hunt sends second letter to Epilepsy Society
Epilepsy Society's chief executive, Clare Pelham, has welcomed a second letter from the Department of Health in response to her letter to health secretary Jeremy Hunt, calling for mandatory reviews for women and girls of childbearing age taking sodium valproate.
Arlene Foster and DUP support Epilepsy Society sodium valproate campaign
Arlene Foster, leader of the Democratic Unionist Party and First Minister of Northern Ireland has pledged her support for Epilepsy Society's campaign to ensure mandatory reviews for all women and girls of childbearing who take sodium valproate.
Jeremy Hunt responds to Epilepsy Society on sodium valproate
On 21 September 2017, Epilepsy Society's chief executive, Clare Pelham, wrote to health secretary Jeremy Hunt asking him to introduce mandatory annual reviews for any girl or woman of childbearing age who is taking the epilepsy drug sodium valproate.